
REGENXBIO Inc.
USD12.02
+0.19 (+1.59%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.85
Prev. Close
$11.83
Day Low
$11.70
Day High
$12.24
52W Low
$5.46
52W High
$16.19
Market Cap
$0.62B
Volume
0.45M
REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell Therapy's 24th Annual Meeting